Skip to content
DraconiticResearch
Search Sources API
197,761 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

679 Novel 4-thiazolidinone derivative Les-4367 synergizes with trastuzumab and pertuzumab to suppress immune evasion markers in HER2-positive gastric cancer

  • Anna Bielawska1
  • Agnieszka Gornowicz1
  • Magdalena Podolak1
  • Wojciech Szymanowski1
  • Roman Lesyk2
  1. 1Medical University of Bialystok, Bialystok, Poland
  2. 2Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Open at sourcePDFDOICite

Related

  1. Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer
    S. Tam, S. Bahnassy, L. Jin +8
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  2. The novel biguanide derivative 4C synergizes with talazoparib by inducing ferroptosis via the SREBP1/FASN/ SLC7A11/GPX4 axis in bladder cancer
    Jia Yao, Weifan Wang, Duo Li +4
    Cell Death DiscoveryPeer-reviewedCC BYFull textGeneral biochemistryCell biologyDOAJ
  3. Real-world comparative outcomes of pyrotinib-based versus pertuzumab-based first-line therapy in HER2-Positive advanced breast cancer: a multicenter retrospective cohort study from Xinjiang, China
    Yimuran Hujiahemaiti, Yinping Ge, Chao Zhang +11
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCEurope PMCPMC
  4. Stabilizing the CHI3L1-Gal3BP complex remodels the glioblastoma immune microenvironment and synergizes with PD-1 blockade
    S. Upadhyay, L. Zhang, M. Teplova +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxivPMC
  5. Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma
    Joshua Robert Goulding, Stijn Tim Couwenbergh, Sarah-Lee Bekaert +12
    Cell ReportsPeer-reviewedCC BY-NC-ND 4.0NeurologyCrossref

Cite

BibTeXRIS
BibTeX
@article{bielawska2026novel,
  title = {{679 Novel 4-thiazolidinone derivative Les-4367 synergizes with trastuzumab and pertuzumab to suppress immune evasion markers in HER2-positive gastric cancer}},
  author = {Anna Bielawska and Agnieszka Gornowicz and Magdalena Podolak and Wojciech Szymanowski and Roman Lesyk},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0679},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0679},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 679 Novel 4-thiazolidinone derivative Les-4367 synergizes with trastuzumab and pertuzumab to suppress immune evasion markers in HER2-positive gastric cancer
AU  - Anna Bielawska
AU  - Agnieszka Gornowicz
AU  - Magdalena Podolak
AU  - Wojciech Szymanowski
AU  - Roman Lesyk
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0679
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0679
SN  - 2051-1426
ER  -